Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties

Digestive and Liver Disease

Volumn 40, Issue 12, 2008, Pages 963-964

  Baglioni, M ^a   Fiume, L ^a   Bolondi, L ^b   Farina, C ^c   Kratz, F ^d   Di Stefano, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Kedrion   (Italy)

^d TUMOR BIOLOGY CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HUMAN ALBUMIN;

ADSORPTION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG PENETRATION; DRUG TARGETING; HUMAN; LETTER; LIVER CELL CARCINOMA; NONHUMAN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DESIGN; HUMANS; LIVER NEOPLASMS; RATS; SERUM ALBUMIN;

EID: 54249138300     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.05.014     Document Type: Letter

References (13)

1. Di Stefano G., Lanza M., Kratz F., Merina L., and Fiume L. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. Eur J Pharm Sci 23 (2004) 393-397
2. Trerè D., Fiume L., Badiali De Giorgi L., Di Stefano G., and Migaldi M. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells. Br J Cancer 81 (1999) 404-408
3. Morell A.G., Irvine R.A., Sternlieb I., Scheinberg I.H., and Ashwell G. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem 243 (1968) 155-159
4. Wilson G. Effect of reductive lactosamination on the hepatic uptake of bovine pancreatic ribonuclease A dimer. J Biol Chem 253 (1978) 2070-2072
5. Fiume L., Busi C., Mattioli A., and Barbanti-Brodano G. Hepatocyte targeting of adenine-9-β-d-arabinofuranoside 5′-monophosphate (ara-AMP) coupled to lactosaminated albumin. FEBS Lett 129 (1981) 261-264
6. Di Stefano G., Fiume L., Baglioni M., Bolondi L., Busi C., Chieco P., et al. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver Int 26 (2006) 726-733
7. Di Stefano G., Fiume L., Bolondi L., Lanza M., Pariali M., and Chieco P. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumours. Liver Int 25 (2005) 854-860
8. Kratz F., Roth T., Fichiner I., Schumacher P., Fiebig H.H., and Unger C. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model. J Drug Targ 8 (2000) 305-318
9. Goomaghtigh E., Chatelain P., Caspers J., and Ruysschaert J.M. Evidence of a specific complex between adriamycin and negatively charged phospholipids. Biochim Biophys Acta 597 (1980) 1-14
10. Fiume L., Bolondi L., Busi C., Chieco P., Kratz F., Lanza M., et al. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. J Hepatol 43 (2005) 645-652
11. Di Stefano G., Fiume L., Baglioni M., Bolondi L., Chieco P., Kratz F., et al. Efficacy of doxorubicin coupled to lactosaminated albumin on rat HCCs evaluated by ultrasound imaging. Dig Liver Dis 40 (2008) 278-284
12. Fukumura D., Yuan F., Monsky L., Chen Y., and Jain R.K. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151 (1997) 679-688
13. Di Stefano G., Fiume L., Baglioni M., Busi C., Bolondi L., Farina C., et al. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. Eur J Pharm Sci 33 (2008) 191-198